Literature DB >> 34268079

The effect of atrial fibrillation on perioperative outcomes in patients with pancreatic cancer undergoing open pancreaticoduodenectomy: analysis of the National Inpatient Sample.

Pu Han1, Yifeng Yang2, Yanjie He3, Hongwei Wu1, Dong Wang1, Kun Liu1, Chengjian Guan1, Xiaodong Zhang1, Wei Guo1, Zhongtao Zhang1.   

Abstract

BACKGROUND: To assess the role of atrial fibrillation on perioperative outcomes in patients with pancreatic cancer undergoing open pancreaticoduodenectomy (OPD).
METHODS: We investigated patients with pancreatic cancer undergoing OPD during 2012-2014 within National Inpatient Sample database. The study population was divided into two groups based on the presence of atrial fibrillation. In-hospital mortality, length of stay, cost of hospitalization, and in-hospital complications were compared between the two groups. Logistic regression models and linear regression were used to adjust for potential confounders. Propensity score matching was also utilized.
RESULTS: Of the 12,785 patients aged ≥18 years undergoing OPD during years 2012-2014, 11,469 (90%) had no atrial fibrillation and 1,316 (10%) had atrial fibrillation. Patients with atrial fibrillation were found to have significantly higher cost, but similar mortality and LOS compared to those without atrial fibrillation. The risk of gastrointestinal anastomotic leakage, cardiac complications, respiratory complications, pulmonary embolism, and perioperative shock were found to be significantly higher in atrial fibrillation group than non-atrial fibrillation group in both multivariate regression model and propensity score matching model. In older patients (>65 years), atrial fibrillation was found to be associated with a significantly higher cost, longer hospital stays, higher incidence of cardiac complications, respiratory complications, and postoperative shock, yet similar mortality.
CONCLUSIONS: Atrial fibrillation was found to be associated with higher cost in pancreatic cancer patients undergoing OPD, as well as increased occurrence of cardiac complications, respiratory complications, pulmonary embolism, and perioperative shock. Surgeons should pay special attention to patients with atrial fibrillation, and consider working together with cardiologists and anesthesiologists to jointly develop a management plan. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Pancreatic cancer; atrial fibrillation; complication; pancreaticoduodenectomy (PD)

Year:  2021        PMID: 34268079      PMCID: PMC8258882          DOI: 10.21037/gs-21-116

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  37 in total

1.  Atrial fibrillation and the urologist.

Authors:  Khurshid R Ghani; Ken M Anson; A John Camm
Journal:  BJU Int       Date:  2004-08       Impact factor: 5.588

2.  Risk of morbidity and mortality following hepato-pancreato-biliary surgery.

Authors:  Peter J Kneuertz; Henry A Pitt; Karl Y Bilimoria; Jill P Smiley; Mark E Cohen; Clifford Y Ko; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2012-07-04       Impact factor: 3.452

3.  Two thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Jin He
Journal:  J Am Coll Surg       Date:  2015-01-06       Impact factor: 6.113

4.  One thousand consecutive pancreaticoduodenectomies.

Authors:  John L Cameron; Taylor S Riall; JoAnn Coleman; Kenneth A Belcher
Journal:  Ann Surg       Date:  2006-07       Impact factor: 12.969

5.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 6.  Pathophysiology after pancreaticoduodenectomy.

Authors:  Chang Moo Kang; Jin Ho Lee
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

7.  Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry.

Authors:  Jan Beyer-Westendorf; Vera Gelbricht; Kati Förster; Franziska Ebertz; Christina Köhler; Sebastian Werth; Eberhard Kuhlisch; Thoralf Stange; Christoph Thieme; Katharina Daschkow; Norbert Weiss
Journal:  Eur Heart J       Date:  2014-01-06       Impact factor: 29.983

8.  Prognostic Significance of Postoperative Complications After Curative Resection for Patients With Esophageal Squamous Cell Carcinoma.

Authors:  Hiroshi Saeki; Satoshi Tsutsumi; Hirotada Tajiri; Takafumi Yukaya; Ryosuke Tsutsumi; Sho Nishimura; Yu Nakaji; Kensuke Kudou; Shingo Akiyama; Yuta Kasagi; Ryota Nakanishi; Yuichiro Nakashima; Masahiko Sugiyama; Kippei Ohgaki; Hideto Sonoda; Eiji Oki; Yoshihiko Maehara
Journal:  Ann Surg       Date:  2017-03       Impact factor: 12.969

9.  Facing the surgeon's nightmare: Incidence and management of postoperative pancreatic fistulas grade C after pancreaticoduodenectomy based on the updated definition of the International Study Group of Pancreatic Surgery (ISGPS).

Authors:  Andreas Minh Luu; Lukas Krasemann; Tim Fahlbusch; Orlin Belyaev; Monika Janot-Matuschek; Waldemar Uhl; Chris Braumann
Journal:  J Hepatobiliary Pancreat Sci       Date:  2020-02-14       Impact factor: 7.027

10.  Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy.

Authors:  Satoshi Higuchi; Yusuke Kabeya; Kenichi Matsushita; Nobuaki Arai; Keisei Tachibana; Ryota Tanaka; Riken Kawachi; Hidefumi Takei; Yutaka Suzuki; Masaharu Kogure; Yorihisa Imanishi; Kiyoshi Moriyama; Tomoko Yorozu; Koichiro Saito; Nobutsugu Abe; Masanori Sugiyama; Haruhiko Kondo; Hideaki Yoshino
Journal:  PLoS One       Date:  2019-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.